Memantine and Donepezil
Memantine and Donepezil is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including Memantine and Donepezil Hydrochlorides Extended-release, Memantine and Donepezil. Available dosage form: capsule, extended release.
Drug Details
- Generic Name
- Memantine and Donepezil
- Brand Names
- Memantine and Donepezil Hydrochlorides Extended-release, Memantine and Donepezil
- Application Number
- ANDA208328
- Sponsor
- Amneal Pharmaceuticals NY LLC
- NDC Codes
- 7
- Dosage Forms
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- MEMANTINE HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Memantine and donepezil hydrochlorides extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily. Memantine and donepezil hydrochlorides extended-release capsules are a combination of memantine hydrochloride, an NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor, indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily. ( 1 )